Chen P W, Murray T G, Salgaller M L, Ksander B R
Schepens Eye Research Institute, Boston, MA 02114, USA.
J Immunother. 1997 Jul;20(4):265-75. doi: 10.1097/00002371-199707000-00003.
The pathobiology of melanomas that develop within the eye is distinct from melanomas that develop within the subcutaneous tissues of the skin. This may be related to the unique structural and functional differences between normal melanocytes present within the uveal tract of the eye and the epidermal layers of the skin. The purpose of the present study was to determine whether normal pigmented cells within the eye (melanocytes and retinal pigment epithelial cells) and cultured cells derived from malignant ocular melanomas express the MAGE genes that encode tumor antigens that are recognized by specific CD8+ cytotoxic T lymphocytes. In the present series of experiments, we examined MAGE expression in cultured ocular melanoma cells obtained from a group of 17 ocular melanoma patients. Normal ocular melanocytes and retinal pigment epithelial cells were recovered and cultured from eyes enucleated for trauma. MAGE gene expression was determined using reverse transcription-polymerase chain reaction specific for either MAGE-1, -2, or -3. Our results demonstrate that MAGE-1, MAGE-2, and MAGE-3 genes are transcribed in primary ocular melanoma cell lines and are detected in cells recovered from 41, 53, and 53% of the patients examined, respectively. Normal choroidal melanocytes and retinal pigment epithelial cells did not express MAGE genes. We conclude that cultured ocular melanoma cell lines express MAGE-1, MAGE-2, and MAGE-3 genes.
眼部发生的黑色素瘤的病理生物学与皮肤皮下组织中发生的黑色素瘤不同。这可能与眼部葡萄膜内的正常黑素细胞和皮肤表皮层之间独特的结构和功能差异有关。本研究的目的是确定眼部正常色素细胞(黑素细胞和视网膜色素上皮细胞)以及源自恶性眼黑色素瘤的培养细胞是否表达MAGE基因,这些基因编码可被特定CD8 +细胞毒性T淋巴细胞识别的肿瘤抗原。在本系列实验中,我们检测了从17例眼黑色素瘤患者组中获得的培养眼黑色素瘤细胞中的MAGE表达。从因外伤而摘除的眼睛中回收并培养正常眼黑素细胞和视网膜色素上皮细胞。使用针对MAGE-1、-2或-3的逆转录-聚合酶链反应来确定MAGE基因表达。我们的结果表明,MAGE-1、MAGE-2和MAGE-3基因在原发性眼黑色素瘤细胞系中被转录,并且分别在41%、53%和53%的受检患者的细胞中被检测到。正常脉络膜黑素细胞和视网膜色素上皮细胞不表达MAGE基因。我们得出结论,培养的眼黑色素瘤细胞系表达MAGE-1、MAGE-2和MAGE-3基因。